NewEdge Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-32,692
Closed -$218K 4109
2025
Q2
$218K Buy
+32,692
New +$168K ﹤0.01% 2187
2025
Q1
Sell
-200
Closed -$1.61K 3967
2024
Q4
$1.61K Hold
200
﹤0.01% 3488
2024
Q3
$1.63K Sell
200
-7,636
-97% -$50.3K ﹤0.01% 3421
2024
Q2
$54.6K Sell
7,836
-4,300
-35% -$32.5K ﹤0.01% 2312
2024
Q1
$129K Buy
12,136
+605
+5% +$5.29K ﹤0.01% 1987
2023
Q4
$92.5K Sell
11,531
-94
-0.8% -$685 ﹤0.01% 1977
2023
Q3
$95.6K Sell
11,625
-986
-8% -$8.5K ﹤0.01% 1850
2023
Q2
$101K Buy
12,611
+1,690
+15% +$12.5K ﹤0.01% 1849
2023
Q1
$88.5K Sell
10,921
-112
-1% -$899 ﹤0.01% 1787
2022
Q4
$772 Sell
11,033
-622
-5% -$4.34K ﹤0.01% 3096
2022
Q3
$80K Buy
11,655
+278
+2% +$1.93K ﹤0.01% 1468
2022
Q2
$95K Buy
+11,377
New +$159K ﹤0.01% 1484
2017
Q3
Sell
-23
Closed -$383 436
2017
Q2
$383 Buy
+23
New +$276 ﹤0.01% 1373

Other funds holding BHC

NewEdge Advisors's BHC Position: Q3 2025 in Review

NewEdge Advisors sold out of Bausch Health (BHC) in Q3 2025, closing a stake of 32,692 shares — an estimated $218K sold.

NewEdge Advisors first reported a position in BHC in Q2 2017 and held it in 13 quarters. The position peaked at $218K in Q2 2025. 219 funds tracked by Wall St. Rank hold BHC as of Q3 2025.

  • NewEdge Advisors reported no remaining Bausch Health position as of Q3 2025 after selling out during the quarter.
  • NewEdge Advisors sold 32,692 Bausch Health shares in Q3 2025, an estimated $218K.
  • NewEdge Advisors first reported a position in Bausch Health in Q2 2017 and held it in 13 quarters.
  • NewEdge Advisors's Bausch Health position peaked at $218K in Q2 2025.
  • 219 funds tracked by Wall St. Rank held Bausch Health as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.